Susquehanna International Group, LLP Obs Eva Sa Call Options Transaction History

Susquehanna International Group, LLP

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	BUY	$1.34 - $2.08 $38,726 - $60,112	28,900 Added 192.67%	43,900 $71,000
Q1 2022 May 16, 2022	SELL	$1.1 - $2.17 $130,240 - $256,928	-118,400 Reduced 88.76%	15,000 $23,000
Q4 2021 Feb 14, 2022	SELL	$1.99 - $3.1 $359,593 - $560,170	-180,700 Reduced 57.53%	133,400 $265,000
Q3 2021 Nov 15, 2021	BUY	$2.47 - $3.34 $519,441 - $702,402	210,300 Added 202.6%	314,100 $977,000
Q2 2021 Aug 11, 2021	SELL	$2.56 - $3.35 $578,048 - $756,430	-225,800 Reduced 68.51%	103,800 $315,000

Q1 2021 May 17, 2021	BUY	$2.01 - $5.05 $545,715 - $1.37 Million	271,500 Added 467.3%	329,600 $1.07 Million
Q4 2020 Feb 16, 2021	BUY	$1.89 - $2.55 $36,288 - $48,960	19,200 Added 49.36%	58,100 $121,000
Q3 2020 Nov 16, 2020	BUY	$2.46 - $6.15 $95,694 - $239,235	38,900 New	38,900 $96,000

88K

Ticker OBSV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,499,200
Description
ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.